Skip to content

Clinical trials

Observational Multiple Myeloma trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Myeloma Phase: Observational Country / region: Austria Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20102
20151
20173
20202
20212
20221
20232
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting3
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celgene3
Janssen Pharmaceutica N.V., Belgium2
Medical University Innsbruck2
Amgen1
European Myeloma Network B.V.1
Medical University of Vienna1
Sandoz1
Sanofi1
Stichting European Myeloma Network1
iOMEDICO AG1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Myeloma14
Breast Neoplasms1
COVID-191
Corneal Diseases1
Coronavirus Infections1
Febrile Neutropenia1
Infections1
Leukemia, B-Cell1
Leukemia, Plasma Cell1
Lung Neoplasms1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.